Copper in Medicine: Homeostasis, Chelation Therapy and Antitumor Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|5|525-537

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.5, 2006-03, pp. : 525-537

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiangiogenic therapy through copper chelation

By Sproull Mary   Brechbiel Martin   Camphausen Kevin  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 3, 2003-06 ,pp. : 405-409

Informa Healthcare

Access to resources Recommend Favorite

Essentiality, Toxicology and Chelation Therapy of Zinc and Copper

By  

Current Medicinal Chemistry, Vol. 12, Iss. 23, 2005-11 ,pp. : 2753-2763

Bentham Science Publishers

Access to resources Recommend Favorite

Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm

By Khan Gazala   Merajver Sofia  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 541-548

Informa Healthcare

Access to resources Recommend Favorite

Drug Combinations with Proteasome Inhibitors in Antitumor Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 4094-4114

Bentham Science Publishers

Access to resources Recommend Favorite

The use of copper-lowering therapy with tetrathiomolybdate in medicine

By Brewer George J  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 1, 2009-01 ,pp. : 89-97

Informa Healthcare

Access to resources Recommend Favorite